Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

One-Fifth of Children with Sickle Cell Anemia Show Exercise-Induced Hemoglobin Desaturation: Rate of Perceived Exertion and Role of Blood Rheology.

Brousse V, Pondarre C, Arnaud C, Kamden A, de Montalembert M, Boutonnat-Faucher B, Bourdeau H, Charlot K, Grévent D, Verlhac S, da Costa L, Connes P.

J Clin Med. 2020 Jan 3;9(1). pii: E133. doi: 10.3390/jcm9010133.

2.

Innate immune cells, major protagonists of sickle cell disease pathophysiology.

Allali S, Maciel TT, Hermine O, de Montalembert M.

Haematologica. 2020 Jan 31;105(2):273-283. doi: 10.3324/haematol.2019.229989. Print 2020. Review.

3.

Mortality in children with sickle cell disease in mainland France from 2000 to 2015.

Desselas E, Thuret I, Kaguelidou F, Benkerrou M, de Montalembert M, Odièvre MH, Lesprit E, Rumpler E, Fontanet A, Pondarre C, Brousse V.

Haematologica. 2020 Jan 9. pii: haematol.2019.237602. doi: 10.3324/haematol.2019.237602. [Epub ahead of print] No abstract available.

4.

Diagnosing gaze and arrow cueing effects in unilateral spatial neglect.

Narison R, De Montalembert M, Conty L.

Neurocase. 2020 Feb;26(1):42-50. doi: 10.1080/13554794.2019.1705495. Epub 2019 Dec 19.

PMID:
31856672
5.

Sickle cell disease: a comprehensive program of care from birth.

de Montalembert M, Tshilolo L, Allali S.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):490-495. doi: 10.1182/hematology.2019000053.

PMID:
31808910
6.

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update.

Iolascon A, De Franceschi L, Muckenthaler M, Taher A, Rees D, de Montalembert M, Rivella S, Eleftheriou A, Cappellini MD.

Hemasphere. 2019 Jun 4;3(3):e208. doi: 10.1097/HS9.0000000000000208. eCollection 2019 Jun. Review.

7.

[Newborn screening of sickle cell disease and management of care.]

Allaf B, Couque N, de Montalembert M.

Rev Prat. 2019 Apr;69(4):411-416. Review. French.

PMID:
31626498
8.

Hepatobiliary Complications in Children with Sickle Cell Disease: A Retrospective Review of Medical Records from 616 Patients.

Allali S, de Montalembert M, Brousse V, Heilbronner C, Taylor M, Brice J, Manzali E, Garcelon N, Lacaille F.

J Clin Med. 2019 Sep 18;8(9). pii: E1481. doi: 10.3390/jcm8091481.

9.

Insights into determinants of spleen injury in sickle cell anemia.

El Hoss S, Cochet S, Marin M, Lapouméroulie C, Dussiot M, Bouazza N, Elie C, de Montalembert M, Arnaud C, Guitton C, Pellegrino B, Odièvre MH, Moati F, Le Van Kim C, Aronovicz YC, El Nemer W, Brousse V.

Blood Adv. 2019 Aug 13;3(15):2328-2336. doi: 10.1182/bloodadvances.2019000106.

10.

Transfusing children with hemoglobinopathies.

Allali S, Taylor M, Albinni S, Amiranoff D, de Montalembert M.

Transfus Clin Biol. 2019 Sep;26(3):147-149. doi: 10.1016/j.tracli.2019.06.323. Epub 2019 Jun 29. Review.

PMID:
31300265
11.

Innate-like T cells in children with sickle cell disease.

Allali S, Dietrich C, Machavoine F, Rignault-Bricard R, Brousse V, de Montalembert M, Hermine O, Maciel TT, Leite-de-Moraes M.

PLoS One. 2019 Jun 28;14(6):e0219047. doi: 10.1371/journal.pone.0219047. eCollection 2019.

12.

Plasma histamine elevation in a large cohort of sickle cell disease patients.

Allali S, Lionnet F, Mattioni S, Callebert J, Stankovic Stojanovic K, Bachmeyer C, Arlet JB, Brousse V, de Montalembert M, Chalumeau M, Grateau G, Maciel TT, Launay JM, Hermine O, Georgin-Lavialle S.

Br J Haematol. 2019 Jul;186(1):125-129. doi: 10.1111/bjh.15900. Epub 2019 Mar 28.

PMID:
30924132
13.

Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.

Naik RP, Smith-Whitley K, Hassell KL, Umeh NI, de Montalembert M, Sahota P, Haywood C Jr, Jenkins J, Lloyd-Puryear MA, Joiner CH, Bonham VL, Kato GJ.

Ann Intern Med. 2018 Nov 6;169(9):619-627. doi: 10.7326/M18-1161. Epub 2018 Oct 30.

14.

Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.

Lobitz S, Telfer P, Cela E, Allaf B, Angastiniotis M, Backman Johansson C, Badens C, Bento C, Bouva MJ, Canatan D, Charlton M, Coppinger C, Daniel Y, de Montalembert M, Ducoroy P, Dulin E, Fingerhut R, Frömmel C, García-Morin M, Gulbis B, Holtkamp U, Inusa B, James J, Kleanthous M, Klein J, Kunz JB, Langabeer L, Lapouméroulie C, Marcao A, Marín Soria JL, McMahon C, Ohene-Frempong K, Périni JM, Piel FB, Russo G, Sainati L, Schmugge M, Streetly A, Tshilolo L, Turner C, Venturelli D, Vilarinho L, Yahyaoui R, Elion J, Colombatti R; with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases.

Br J Haematol. 2018 Nov;183(4):648-660. doi: 10.1111/bjh.15600. Epub 2018 Oct 18.

15.

Prognostic factors of disease severity in infants with sickle cell anemia: A comprehensive longitudinal cohort study.

Brousse V, El Hoss S, Bouazza N, Arnaud C, Bernaudin F, Pellegrino B, Guitton C, Odièvre-Montanié MH, Mames D, Brouzes C, Picard V, Nguyen-Khoa T, Pereira C, Lapouméroulie C, Pissard S, Gardner K, Menzel S, Le Van Kim C, Colin-Aronovicz Y, Buffet P, Mohandas N, Elie C, Maier-Redelsperger M, El Nemer W, de Montalembert M.

Am J Hematol. 2018 Nov;93(11):1411-1419. doi: 10.1002/ajh.25260. Epub 2018 Sep 21.

16.

Paramacular temporal atrophy in sickle cell disease occurs early in childhood.

Martin GC, Albuisson E, Brousse V, de Montalembert M, Bremond-Gignac D, Robert MP.

Br J Ophthalmol. 2019 Jul;103(7):906-910. doi: 10.1136/bjophthalmol-2018-312305. Epub 2018 Aug 21.

PMID:
30131379
17.

Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.

Allali S, Chalumeau M, Launay O, Ballas SK, de Montalembert M.

Cochrane Database Syst Rev. 2018 Aug 20;8:CD011199. doi: 10.1002/14651858.CD011199.pub3.

18.

CD34+ Hematopoietic Stem Cell Count Is Predictive of Vascular Event Occurrence in Children with Sickle Cell Disease.

Kossorotoff M, De Montalembert M, Brousse V, Lasne D, Curis E, Smadja DM, Lacroix R, Bertil S, Masson E, Desguerre I, Bonnet D, Gaussem P.

Stem Cell Rev Rep. 2018 Oct;14(5):694-701. doi: 10.1007/s12015-018-9835-8.

PMID:
29931411
19.

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Magnani A, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2018 Apr 19;378(16):1479-1493. doi: 10.1056/NEJMoa1705342.

20.

Transfusion-related adverse events are decreased in pregnant women with sickle cell disease by a change in policy from systematic transfusion to prophylactic oxygen therapy at home: A retrospective survey by the international sickle cell disease observatory.

Ribeil JA, Labopin M, Stanislas A, Deloison B, Lemercier D, Habibi A, Albinni S, Charlier C, Lortholary O, Lefrere F, De Montalembert M, Blanche S, Galactéros F, Tréluyer JM, Gluckman E, Ville Y, Joseph L, Delville M, Benachi A, Cavazzana M.

Am J Hematol. 2018 Jun;93(6):794-802. doi: 10.1002/ajh.25097. Epub 2018 Apr 17.

21.

Early Noninvasive Ventilation and Nonroutine Transfusion for Acute Chest Syndrome in Sickle Cell Disease in Children: A Descriptive Study.

Heilbronner C, Merckx A, Brousse V, Allali S, Hubert P, de Montalembert M, Lesage F.

Pediatr Crit Care Med. 2018 May;19(5):e235-e241. doi: 10.1097/PCC.0000000000001468.

PMID:
29356722
22.

Coexistent sickle-cell anemia and autoimmune disease in eight children: pitfalls and challenges.

Li-Thiao-Te V, Uettwiller F, Quartier P, Lacaille F, Bader-Meunier B, Brousse V, de Montalembert M.

Pediatr Rheumatol Online J. 2018 Jan 17;16(1):5. doi: 10.1186/s12969-017-0221-x.

23.

Are the risks of treatment to cure a child with severe sickle cell disease too high?

de Montalembert M, Brousse V, Chakravorty S, Pagliuca A, Porter J, Telfer P, Vora A, Rees DC.

BMJ. 2017 Nov 23;359:j5250. doi: 10.1136/bmj.j5250. No abstract available.

PMID:
29170154
24.

Anemia in children: prevalence, causes, diagnostic work-up, and long-term consequences.

Allali S, Brousse V, Sacri AS, Chalumeau M, de Montalembert M.

Expert Rev Hematol. 2017 Nov;10(11):1023-1028. doi: 10.1080/17474086.2017.1354696. Epub 2017 Oct 12. Review.

PMID:
29023171
25.

Visual Function in Asymptomatic Patients With Homozygous Sickle Cell Disease and Temporal Macular Atrophy.

Martin GC, Dénier C, Zambrowski O, Grévent D, Bruère L, Brousse V, de Montalembert M, Brémond-Gignac D, Robert MP.

JAMA Ophthalmol. 2017 Oct 1;135(10):1100-1105. doi: 10.1001/jamaophthalmol.2017.3008.

26.

Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).

Chevret S, Verlhac S, Ducros-Miralles E, Dalle JH, de Latour RP, de Montalembert M, Benkerrou M, Pondarré C, Thuret I, Guitton C, Lesprit E, Etienne-Julan M, Elana G, Vannier JP, Lutz P, Neven B, Galambrun C, Paillard C, Runel C, Jubert C, Arnaud C, Kamdem A, Brousse V, Missud F, Petras M, Doumdo-Divialle L, Berger C, Fréard F, Taieb O, Drain E, Elmaleh M, Vasile M, Khelif Y, Bernaudin M, Chadebech P, Pirenne F, Socié G, Bernaudin F.

Contemp Clin Trials. 2017 Nov;62:91-104. doi: 10.1016/j.cct.2017.08.008. Epub 2017 Aug 15.

PMID:
28821470
27.

Management of iron overload in hemoglobinopathies.

Allali S, de Montalembert M, Brousse V, Chalumeau M, Karim Z.

Transfus Clin Biol. 2017 Sep;24(3):223-226. doi: 10.1016/j.tracli.2017.06.008. Epub 2017 Jun 30. Review.

PMID:
28673501
28.

Recommendations regarding splenectomy in hereditary hemolytic anemias.

Iolascon A, Andolfo I, Barcellini W, Corcione F, Garçon L, De Franceschi L, Pignata C, Graziadei G, Pospisilova D, Rees DC, de Montalembert M, Rivella S, Gambale A, Russo R, Ribeiro L, Vives-Corrons J, Martinez PA, Kattamis A, Gulbis B, Cappellini MD, Roberts I, Tamary H; Working Study Group on Red Cells and Iron of the EHA.

Haematologica. 2017 Aug;102(8):1304-1313. doi: 10.3324/haematol.2016.161166. Epub 2017 May 26.

29.

Very low prevalence of iron deficiency among young French children: A national cross-sectional hospital-based survey.

Sacri AS, Hercberg S, Gouya L, Levy C, Bocquet A, Blondel B, Vincelet C, Hebel P, Vinatier I, de Montalembert M, Barros H, Le Strat Y, Chalumeau M.

Matern Child Nutr. 2018 Jan;14(1). doi: 10.1111/mcn.12460. Epub 2017 May 3.

PMID:
28466606
30.

Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.

Allali S, Peyrard T, Amiranoff D, Cohen JF, Chalumeau M, Brousse V, de Montalembert M.

Br J Haematol. 2017 May;177(4):641-647. doi: 10.1111/bjh.14609. Epub 2017 Apr 12.

PMID:
28402005
31.

Long-term Outcome After Multiple Burr Hole Surgery in Children With Moyamoya Angiopathy: A Single-Center Experience in 108 Hemispheres.

Blauwblomme T, Mathon B, Naggara O, Kossorotoff M, Bourgeois M, Puget S, Meyer P, Brousse V, de Montalembert M, Brunelle F, Zerah M, Sainte-Rose C.

Neurosurgery. 2017 Jun 1;80(6):950-956. doi: 10.1093/neuros/nyw161.

PMID:
28327981
32.

Family cord blood banking for sickle cell disease: a twenty-year experience in two dedicated public cord blood banks.

Rafii H, Bernaudin F, Rouard H, Vanneaux V, Ruggeri A, Cavazzana M, Gauthereau V, Stanislas A, Benkerrou M, De Montalembert M, Ferry C, Girot R, Arnaud C, Kamdem A, Gour J, Touboul C, Cras A, Kuentz M, Rieux C, Volt F, Cappelli B, Maio KT, Paviglianiti A, Kenzey C, Larghero J, Gluckman E.

Haematologica. 2017 Jun;102(6):976-983. doi: 10.3324/haematol.2016.163055. Epub 2017 Mar 16.

33.

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome.

de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C.

PLoS One. 2017 Mar 3;12(3):e0172147. doi: 10.1371/journal.pone.0172147. eCollection 2017.

34.

Gene Therapy in a Patient with Sickle Cell Disease.

Ribeil JA, Hacein-Bey-Abina S, Payen E, Magnani A, Semeraro M, Magrin E, Caccavelli L, Neven B, Bourget P, El Nemer W, Bartolucci P, Weber L, Puy H, Meritet JF, Grevent D, Beuzard Y, Chrétien S, Lefebvre T, Ross RW, Negre O, Veres G, Sandler L, Soni S, de Montalembert M, Blanche S, Leboulch P, Cavazzana M.

N Engl J Med. 2017 Mar 2;376(9):848-855. doi: 10.1056/NEJMoa1609677.

35.

Sickle cell disease.

Ware RE, de Montalembert M, Tshilolo L, Abboud MR.

Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1. Review.

PMID:
28159390
36.

Associations between environmental factors and hospital admissions for sickle cell disease.

Piel FB, Tewari S, Brousse V, Analitis A, Font A, Menzel S, Chakravorty S, Thein SL, Inusa B, Telfer P, de Montalembert M, Fuller GW, Katsouyanni K, Rees DC.

Haematologica. 2017 Apr;102(4):666-675. doi: 10.3324/haematol.2016.154245. Epub 2016 Dec 1.

37.

Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.

Aubart M, Ou P, Elie C, Canniffe C, Kutty S, Delos V, Graffigne C, de Montalembert M, Brousse V.

J Pediatr Hematol Oncol. 2016 Oct;38(7):497-502. doi: 10.1097/MPH.0000000000000595.

PMID:
27548334
38.

Time perception of simultaneous and sequential events in early-onset schizophrenia.

de Montalembert M, Coulon N, Cohen D, Bonnot O, Tordjman S.

Neurocase. 2016 Aug;22(4):392-9. doi: 10.1080/13554794.2016.1205098. Epub 2016 Jul 7.

PMID:
27388526
39.

Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.

Allali S, Chalumeau M, Launay O, Ballas SK, de Montalembert M.

Cochrane Database Syst Rev. 2016 Feb 16;2:CD011199. doi: 10.1002/14651858.CD011199.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Aug 20;8:CD011199.

PMID:
26881484
40.

[Time perception and schizophrenia: Phenomenological and neuropsychological approach].

de Montalembert M, Tordjman S, Bonnot O, Coulon N.

Encephale. 2015 Sep;41(4 Suppl 1):S56-61. doi: 10.1016/S0013-7006(15)30008-7. Review. French.

PMID:
26746324
41.

Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology.

Brousse V, Colin Y, Pereira C, Arnaud C, Odièvre MH, Boutemy A, Guitton C, de Montalembert M, Lapouméroulie C, Picot J, Le Van Kim C, El Nemer W.

EBioMedicine. 2014 Dec 18;2(2):154-7. doi: 10.1016/j.ebiom.2014.12.006. eCollection 2015.

42.

[Myocardial function and endothelial dysfunction in sickle cell anemia].

de Montalembert M, Kossorotoff M, Bonnet D.

Arch Pediatr. 2015 May;22(5 Suppl 1):113-4. doi: 10.1016/S0929-693X(15)30057-9. French. No abstract available.

PMID:
26112548
43.

Pregnancy in sickle cell disease is at very high risk.

de Montalembert M, Deneux-Tharaux C.

Blood. 2015 May 21;125(21):3216-7. doi: 10.1182/blood-2015-04-638288. No abstract available.

PMID:
25999441
44.

How I manage cerebral vasculopathy in children with sickle cell disease.

Brousse V, Kossorotoff M, de Montalembert M.

Br J Haematol. 2015 Sep;170(5):615-25. doi: 10.1111/bjh.13477. Epub 2015 May 5. Review.

PMID:
25944412
45.

13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.

De Montalembert M, Abboud MR, Fiquet A, Inati A, Lebensburger JD, Kaddah N, Mokhtar G, Piga A, Halasa N, Inusa B, Rees DC, Heath PT, Telfer P, Driscoll C, Al Hajjar S, Tozzi A, Jiang Q, Emini EA, Gruber WC, Gurtman A, Scott DA.

Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23. Erratum in: Pediatr Blood Cancer. 2019 Feb;66(2):e27554.

PMID:
25810327
46.

A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen.

Picot J, Ndour PA, Lefevre SD, El Nemer W, Tawfik H, Galimand J, Da Costa L, Ribeil JA, de Montalembert M, Brousse V, Le Pioufle B, Buffet P, Le Van Kim C, Français O.

Am J Hematol. 2015 Apr;90(4):339-45. doi: 10.1002/ajh.23941. Epub 2015 Feb 2.

47.

[Treatment with hydroxyurea has revolutionized the evolution of sickle cell disease ].

Bartolucci P, de Montalembert M.

Rev Prat. 2014 Oct;64(8):1127-8. French. No abstract available.

PMID:
25510141
48.

Cerebral haemorrhagic risk in children with sickle-cell disease.

Kossorotoff M, Brousse V, Grevent D, Naggara O, Brunelle F, Blauwblomme T, Gaussem P, Desguerre I, De Montalembert M.

Dev Med Child Neurol. 2015 Feb;57(2):187-93. doi: 10.1111/dmcn.12571. Epub 2014 Aug 30.

49.

Imbalanced coagulation profile as a biomarker of migraine in children with sickle cell: Is this a link with cerebral ischemia?

Kossorotoff M, Lasne D, Brousse V, Desguerre I, de Montalembert M, Gaussem P.

J Pediatr. 2014 Sep;165(3):645-6. doi: 10.1016/j.jpeds.2014.05.052. Epub 2014 Jul 9. No abstract available.

PMID:
25015573
50.

Severe nocturnal and postexercise hypoxia in children and adolescents with sickle cell disease.

Halphen I, Elie C, Brousse V, Le Bourgeois M, Allali S, Bonnet D, de Montalembert M.

PLoS One. 2014 May 30;9(5):e97462. doi: 10.1371/journal.pone.0097462. eCollection 2014.

Supplemental Content

Loading ...
Support Center